Shenzhen TargetRx logo — company profile

Shenzhen TargetRx

Founded 2014 51-200 employees Series A Total: $24.14M Health Care

General Information

Company Name Shenzhen TargetRx
Founded Year 2014
Employees 51-200
Industries Health Care
Funding Stage Series A
Social

Get notified when Shenzhen TargetRx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Shenzhen TargetRx

Shenzhen TargetRx is a high-tech pharmaceutical research and development company specializing in the creation of targeted drugs. Established in August 2014 as a Sino-American joint venture, the company received significant funding from prominent angel institutions in China, accumulating a registered capital of RMB 80 million. Founded by renowned medical expert Dr. Yihan Wang, who holds 27 authorized invention patents and has published over 60 papers, the company is focused on the development of small molecule targeted anti-cancer drugs. The recent Series A investment of $21.20M led by Shenzhen Capital Group, CCB International, Oriental Fortune Capital, and Tsing-Yuan Capital stands as a testament to the confidence in Shenzhen TargetRx's mission. With the objective of addressing acquired drug resistance and transforming cancer into a manageable chronic condition, the company is poised to make significant strides in the healthcare industry.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• ••••
04 May 2020
Seed Round •••••• 4
Investor
•••• ••••
24 Jul 2018

Shenzhen TargetRx Alternatives & Competitors

Shenzhen TargetRx vs

Established in 2011, Teligene is a high-tech pharmaceutical research and development company that fo...

Series C
Biotechnology, Health Care
Shenzhen TargetRx vs

Empowering the immune system to combat cancer with precision-targeted therapies

Series A
Biotechnology, Pharmaceutical
Shenzhen TargetRx vs

Improving patient outcomes through innovations in biological therapeutics

Seed
4 employees
Biotechnology, Health Care

FAQ About Shenzhen TargetRx

Founded in August 2014, Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company formed as a Sino-American joint venture. At its inception, the company secured investment from prominent angel institutions in China, with a registered capital of RMB 80 million. Specializi...
Shenzhen TargetRx was founded in 2014.
Shenzhen TargetRx operates in the following industries: Health Care.
Shenzhen TargetRx has approximately 51-200 employees.
Shenzhen TargetRx has completed 2 funding rounds, raising a total of $24.14M. The latest funding stage is Series A.
Top alternatives and competitors to Shenzhen TargetRx include Teligene, MACROPHAGE PHARMA LIMITED, ImmunoBiochem Corporation, Advenchen Laboratories, LLC, FLAG Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Shenzhen TargetRx and Teligene are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Shenzhen TargetRx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy